Azzad Asset Management Inc /Adv Dexcom Inc Transaction History

Azzad Asset Management Inc /Adv

$1.01 Trillion
Q3 2025

A detailed history of Azzad Asset Management Inc /Adv transactions in Dexcom Inc stock. As of the latest transaction made, Azzad Asset Management Inc /Adv holds 13,199 shares of DXCM stock, worth $766,333. This represents 0.09% of its overall portfolio holdings.

Number of Shares

13,199

Previous 4,294 207.38%

Holding current value

$766,333

Previous $375 Million 136.97%

% of portfolio

0.09%

Previous 0.04%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 05, 2025	BUY	$66.46 - $89.53 $591,826 - $797,264	8,905 Added 207.38%	13,199 $888 Million
Q1 2025 Apr 16, 2025	BUY	$67.74 - $90.75 $290,875 - $389,680	4,294 New	4,294 $293 Million
Q3 2024 Oct 07, 2024	SELL	$64.0 - $116.06 $127,488 - $231,191	-1,992 Reduced 4.43%	42,994 $2.88 Billion
Q2 2024 Jul 30, 2024	BUY	$110.31 - $140.45 $220 - $280	2 Added 0.0%	44,986 $5.1 Billion
Q1 2024 Apr 19, 2024	SELL	$114.22 - $140.1 $342 - $420	-3 Reduced 0.01%	44,984 $6.24 Billion
Q4 2023 Apr 01, 2024	BUY	$75.49 - $124.16 $1,887 - $3,104	25 Added 0.06%	44,987 $5.58 Billion
Q3 2023 Apr 01, 2024	BUY	$86.06 - $137.93 $1,721 - $2,758	20 Added 0.04%	44,962 $4.19 Billion
Q2 2023 Apr 01, 2024	SELL	$112.47 - $130.98 $506,002 - $589,279	-4,499 Reduced 9.1%	44,942 $5.78 Billion
Q1 2023 Apr 01, 2024	BUY	$104.0 - $122.92 $3.28 Million - $3.88 Million	31,551 Added 176.36%	49,441 $5.74 Billion
Q4 2022 Apr 01, 2024	SELL	$84.98 - $122.67 $560,103 - $808,517	-6,591 Reduced 26.92%	17,890 $2.03 Billion
Q3 2022 Apr 01, 2024	SELL	$76.35 - $94.18 $152 - $188	-2 Reduced 0.01%	24,481 $4.23 Billion
Q2 2022 Apr 01, 2024	BUY	$67.99 - $132.89 $929,491 - $1.82 Million	13,671 Added 126.44%	24,483 $4.13 Billion
Q1 2022 Apr 01, 2024	BUY	$94.08 - $130.2 $109,415 - $151,422	1,163 Added 12.05%	10,812 $5.53 Billion
Q4 2021 Apr 01, 2024	SELL	$129.87 - $162.82 $1,168 - $1,465	-9 Reduced 0.09%	9,649 $5.18 Billion
Q1 2021 Apr 01, 2024	BUY	$84.79 - $104.74 $66,475 - $82,116	784 Added 8.83%	9,658 $3.47 Billion
Q4 2020 Apr 01, 2024	BUY	$78.0 - $104.5 $79,326 - $106,276	1,017 Added 12.94%	8,874 $3.28 Billion
Q3 2020 Apr 01, 2024	BUY	$95.51 - $112.95 $85,385 - $100,977	894 Added 12.84%	7,857 $3.24 Billion
Q2 2020 Apr 01, 2024	BUY	$62.68 - $105.34 $41,744 - $70,156	666 Added 10.58%	6,963 $2.82 Billion
Q1 2020 Apr 01, 2024	SELL	$47.79 - $75.63 $317,755 - $502,863	-6,649 Reduced 51.36%	6,297 $1.7 Billion
Q3 2019 Apr 01, 2024	BUY	$35.53 - $43.8 $166,067 - $204,721	4,674 Added 56.5%	12,946 $3.72 Billion
Q1 2019 Apr 01, 2024	BUY	$28.07 - $38.18 $7,073 - $9,621	252 Added 3.14%	8,272 $985 Million
Q4 2018 Apr 01, 2024	BUY	$26.99 - $37.37 $39,243 - $54,335	1,454 Added 22.14%	8,020 $961 Million
Q3 2018 Apr 01, 2024	BUY	$23.35 - $36.72 $15,784 - $24,822	676 Added 11.48%	6,566 $939 Million
Q2 2018 Apr 01, 2024	BUY	$17.54 - $25.22 $103,310 - $148,545	5,890 New	5,890 $559 Million
Q2 2017 Apr 03, 2024	SELL	N/A	-39,097	5,890 $431 Million

Others Institutions Holding DXCM

# of Institutions

1,086

Shares Held

358M

Call Options Held

6.13M

Put Options Held

7.3M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $22.4B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Azzad Asset Management Inc /Adv, based on Form 13F filings with the SEC.

News

Stay updated on Azzad Asset Management Inc /Adv with notifications on news.

Account

Azzad Asset Management Inc /Adv Dexcom Inc Transaction History